GLP1R and diabetes mellitus: This may be particularly relevant given the perceived importance of modulation of programmed beta-cell death for both the onset of diabetes (Eizirik et al. 2020), as well as the effectiveness of some antidiabetic therapies including GLP-1 receptor agonists (Kapodistria et al. 2018, Díaz-Megido & Thomsen 2023).